310 likes | 461 Views
Role of Vaccination in Control of BVDV. 2004 NCBA Cattleman’s College. Dan Grooms DVM, Michigan State University, College of Veterinary Medicine. Goal For The Day. Type of BVDV vaccines available Role of vaccines in BVDV control. Seventh Edition of Compendium of Veterinary Products
E N D
Role of Vaccination in Control of BVDV 2004 NCBA Cattleman’s College Dan Grooms DVM, Michigan State University, College of Veterinary Medicine
Goal For The Day • Type of BVDV vaccines available • Role of vaccines in BVDV control
Seventh Edition of Compendium of Veterinary Products 147 BVDV vaccine combinations available
Types of BVDV Vaccines • Killed or inactivated • Modified-live or attenuated
Advantages Generally safer Dead virus Pregnant cows Handling More stable Can use over time if handled correctly Disadvantages Protection not as good Duration Breadth Immune response different than live virus More expensive Triangle 10 ds = $11.85 Pyramid 10 ds = $ 9.69 Killed BVDV Vaccines
Advantages Generally better protection Duration Breadth Immune response more closely mimics natural exposure Cheaper Express 10 ds = $ 8.59 Elite 10 ds = $10.65 Disadvantages Safety Live replicating organism Potential for transmission Potential for mutation Potential of fetal infection Handling Susceptible to inactivation Must use once mixed Modified-Live BVDV Vaccines
2 1a 1b Type of Virus in The Vaccine 1 a & b 2 Continuum of Antigenicity
Chart of MLV BVDV Vaccines Not complete
Chart of Killed BVDV Vaccines Not complete
Location Exposure Time of Year Type of Vaccine Contraindications Considerations IN/SQ/IM Management Economics Animal Use
Pigs Sheep Mucosal Disease Deer? Thrombocytopenia Acute Infection Normal Acute Death Poor Performance BRD Diarrhea Immunosuppression Immunosuppression Fetal Infection Subclinical Infection Persistent Infection Abortions Normal Congenital Defects “Weak Calf” Syndrome
Pigs Sheep Mucosal Disease Deer? Thrombocytopenia Acute Infection Normal Acute Death Poor Performance BRD Diarrhea Immunosuppression Immunosuppression Fetal Infection Subclinical Infection Persistent Infection Abortions Normal Congenital Defects “Weak Calf” Syndrome
Fetal Protection Against BVDV * Protected/Challenged
BVDV Vaccination and Fetal Protection Vaccination for BVDV is not 100%!! Combine with biosecurity and PI management Point #1
2 1a 1b Antigenic Diversity Does a vaccine containing type 1 BVDV protect against a type 2 BVDV challenge (or vice versa)???????
Control Control 100% PI’s MLV Type 1 Vaccine Day 75 Gestation Type 1 Challenge Type 2 Challenge 10 Normal 2 PI’s 11 Normal 8 PI’s 83% Protection 58% Protection Cortese et al AJVR 1998;59:1409 Brock et al Vet Thera 2001;2:354
BVDV Vaccination and Fetal Protection Vaccination for BVDV is not 100%!! Combine with biosecurity and PI management Point #1 It is desirable to provide broad protection against antigenic diversity of BVDV Point #2
Infertility Normal/Abnormal Seropositive Congenital Defects Immunotolerance-PI’s Abortion EED 0 1 2 3 4 5 6 7 8 9 Month Time line of BVDV effects on Bovine Reproduction
BVDV Vaccination and Fetal Protection Vaccination for BVDV is not 100%!! Combine with biosecurity and PI management Point #1 It is desirable to provide broad protection against antigenic diversity of BVDV Point #2 Timing of vaccination should maximize immunity in early pregnancy Point #3
Pigs Sheep Mucosal Disease Deer? Thrombocytopenia Acute Infection Normal Acute Death Poor Performance BRD Diarrhea Immunosuppression Immunosuppression Fetal Infection Subclinical Infection Persistent Infection Abortions Normal Congenital Defects “Weak Calf” Syndrome
Protection Against Acute BVDV Disease • Most experimental studies show good protection against acute disease. • Most studies show protection when vaccine virus and challenge virus are different (type 1 vaccine, type 2 challenge). • No real good large scale field trials looking at vaccine efficacy.
Performance Of Feedlot Cattle Exposed To Animals Persistently Infected With Bovine Viral Diarrhea Virus D.L. Grooms and K.V. Brock
BVDV Vaccination and Acute Infection Protection requirements may not be as stringent as for fetal protection …reasonable cross protection Point #1
BVDV Vaccination and Acute Infection Protection requirements may not be as stringent as for fetal protection …reasonable cross protection Point #1 Vaccination for BVDV is not 100%!! Combine with biosecurity and PI management Point #2
Control and Prevention of BVDV • Biosecurity • Seek and Destroy PI’s • Vaccination Program • Strategic in Timing • Broad Protection Against Virus Diversity
Dan Grooms DVM Michigan State University College of Veterinary Medicine 517-432-1494 groomsd@cvm.msu.edu